SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-295943
Filing Date
2023-12-15
Accepted
2023-12-15 07:45:30
Documents
12
Period of Report
2023-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d451016d8k.htm   iXBRL 8-K 20644
  Complete submission text file 0001193125-23-295943.txt   144567

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA jazz-20231211.xsd EX-101.SCH 2860
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20231211_lab.xml EX-101.LAB 18690
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20231211_pre.xml EX-101.PRE 11693
6 EXTRACTED XBRL INSTANCE DOCUMENT d451016d8k_htm.xml XML 3529
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 231488781
SIC: 2834 Pharmaceutical Preparations